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Preincubation of Serum

Addftlonal Keyphrases: increase in activity in certain diseases
#{149} continuous-flow analysis -discrete analysis ' reference interval 
4-9).
Recently, the DuPont Company has described,5 and is now marketing, a revised AST method6 for use with their ace, based on the recommendations of the IFCC. After an initial review of its performance in our laboratory relative to the original aca method for AST7 and to the routine method for AST with the Technicon SMAC,8 we attempted to modify the AST method for SMAC by incorporating the preincubation step with P5P and thus make it consistent with the revised aca method and the principles of the IFCC and AACC recommendations.
In this report, we describe our modification of the SMAC method for AST and present information on the analytical and clinical performance of both revised automated methods relative to the manual IFCC-recommended method.
Materials and Methods
aca Methods
Reagents for the DuPont aca III included the packs for both the original AST method and the revised AST method. were performed on an aca III. The binary code on the revised-method packs was changed from 4 to 52 by removing the two left-hand black bands (2 + 2 = 48) with an acetone/hexane mixture. The printout for the revised method was changed from "GOT" to "NGOT," to allow simultaneous, unambiguous analysis by both methods. To prolong the preincubation, the AST cartridge on SMAC was modified by adding a second 1.67-mL, 37 #{176}C Kel-F heating bath (Technicon part no. 178-B953-01) in front of the heating bath already in the cartridge (Figure 1 ). The central port on the first heating bath was capped with a nipple fitting; that in the second heating bath was used for the addition of 2-oxoglutarate.
SMAC Methods
Reagents
Total preincubation time is about 4.5 mm and measurement in flowcell number 1 occurs about 1.1 mm after the 2-oxoglutarate is added. 
Manual IFCC Method
Calibration of Methods
Settings on the DuPont aca were adjusted to the theoretical settings for conversion of absorbance change to enzyme activity. We used the aca method to "calibrate" the SMAC method, so as to obtain good agreement between these methods for routine patient care. The SMAC calibration material was assayed five times with the revised AST method in the aca to obtain a new set-point value for the revised method on SMAC. The original value for the routine AST method on SMAC was 163 UIL; the set point for the same material for the revised method on SMAC was 204 U/L.
Studies Performed
We reviewed the effect of the added heating coil on the resulting shape of the peak and quantified this effect by estimating the sample interaction.
The linear range of the revised AST methods was assessed by using patients' sera diluted with de-ionized water for the SMAC method and with 9 g/L saline for the ace method. We also investigated the stability of the new reagents.
We used pools of patients' sara for the within 
Results and Discussion
Analytical Variables
Peak shape and sample interaction. The shape of the peak produced when the modified AST method was used with the SMAC was almost unchanged from that with the original method. The extra heating coil (located in the vacant cartridge space below the AST cartridge) gave 4.5 mm of preincubation. The IFCC recommends a preincubation of 10 min. We did not check for complete saturation of the apoenzyme. However, by comparison, the revised AST method for the DuPont ace provides for a 222-s preincubation.
Interaction. Carryover studies were performed by running in sequence controls of (a) low, (b) low, (c) high, and (d) low AST activity, where "low" was 48 U/L and "high" was 287 U/L. The interaction or carryover was calculated as the ratio of the difference between (d) and (b) to the value of (c). We obtained an average of 2.6% under these conditions for the modified SMAC method. By comparison, the average carryover for the original AST method on SMAC was 2.5%.
Reagent stability.
To assess the stability of the revised SMAC reagents, we prepared reagents freshly each week, stored them for seven weeks at 4 #{176}C. After these seven weeks, we analyzed three controls six times each and six patients' specimens with each of the "lots" of reagents on one day. We saw no significant shifts or trends in means or SDs.
Linearity.
The linear ranges of both revised AST methods were determined by using dilutions of patients' sera. Deionized water was used as diluent for the SMAC method, 9 g/L saline for the aca method. The SMAC method was linear to at least 600 U/L (we have never verified linearity greater than 300 U/L for the original method) and the ace method to at least 800 UIL (vs 600 U/L for the original method).
Within-run precision. Two serum pools were analyzed 21 times each on SMAC to give = 44.1 U/L of AST, SD = 1.9 U/L, and CV = 8.6% for the normal pool and = 150.8 U/L of AST, SD = 2.4 U/L, and CV = 1.6% for the high pool. Table 1 shows our day-to-day replication data for three control materials analyzed on the SMAC. If the allowable error for enzyme assays is 20% (11), the 95% upper limit of the estimate of random error of 11.8 U/L at 48 U/L of enzyme activity is too large. The coefficients of variation for the original SMAC method for these same three control materials were 9.1,3.7, and 2.7% in the same order as listed in Table 1 . There is no major change in the random error of the revised SMAC method as compared with the original method. Table 1 also presents the day-to-day replication statistics for the revised ace method. In all cases for the aca method, the estimates of random error are acceptably small (using the same definition of allowable error as 20%). Again, for comparison purposes, the CV's of the original method for these same control materials are 5.1,4.0, 1.4, and 1.4% in the order listed in Table 1 .
Other Studies
Interference.
The observed interference (Table 2) with the SMAC and ace as shown in Figure 2 (left) was typical of their overall routine performance. We have routinely adjusted the set point-i.e., slope-high to offset a consistently negative intercept of 5 U/L. At the upper limit of normal (35 U/L), the error in the slope (35 X 0.148 = 5.2 U/L) almost exactly nullified the -4.6 U/L intercept. Figure 2 (middle) shows the comparison of the original SMAC AST method to the revised ace method. The unusually large standard error of estimate, more than double that in Figure 2 (left), emphasized that there was a difference between these methods that could not be resolved merely by recalibrating the SMAC method. Figure 2 (right) shows the reduction in the scatter of the results (for the same specimens) to a more typical S,,i. The large bias between the methods indicated additional "fine-tuning" of the set point for the reference material for SMAC was necessary to minimize the error near the upper limit of normal range.
After readjusting the SMAC set point for the AST method, we studied the performance of the SMAC method and the aca method relative to the Manual IFCC method. Figure 3 (left) shows the results for the revised SMAC method vs those of the IFCC method; Figure 3 (middle) shows the ace results vs those of the IFCC method.
Our results for the ace method agree slightly better with those by the IFCC method than reported earlier,6 which compared the revised aca method to the IFCC method adapted to a centrifugal analyzer (y = 1.llx + 8.8 UIL). The revised SMAC method has a bias (+ 6.5 UIL) of a magnitude similar to that for the aca-IFCC data and it is ascribable primarily to the error in slope or in calibration. But we purposely set the calibration of SMAC to give good agreement with the ace method. These two automated methods, compared together in Figure 3 (right) , show a small bias of -1.2 U/L at the mean for the data. Table 3 summarizes the estimates of systematic and total errors for the automated methods relative to one another and to the IFCC method. In all cases, the systematic error is acceptably small. However, the total error, estimated as a combination of random and systematic errors, is too large reported a range of 25-41 U/L. An upper limit of normal of 46 U/L is 31% higher than that for the original AST method (35 UIL). This is consistent with other information we developed ____________________ on comparing the revised and original ace methods. In most instances, we observed about 30% increase in the observed activity of AST as a result of the modifications of the aca method (n = 204, slope = 1.3216, y-intercept = -2.4 U/L, S27i = 22.8 UIL, and r = 0.96 14). Part of this increase may be ascribed to the re-optimization of the method5 and the rest to the effect of the added P5P. The latter implies that, even in healthy people, the circulating P5P is either insufficient to saturate the apoenzyme or it is diluted out by diluents and reagents in the reaction mixture.
We have observed several cases in which the effect of the modified method (added P5P) is to increase the observed AST activity by very much more than 30%; Table 4 shows some examples, as assayed in the ace. These sera mostly are from cases of hepatic disease, dialysis, 61
and myocardial infarction.
In most instances, the enzyme, In summary, we have observed major differences in results for AST by a method that includes preincubation of the serum enzyme with P5P and one that does not. This difference is more than that which can be compensated for by readjustment of a "calibration" factor. To provide within-laboratory consistency for AST assays, we modified the SMAC method to incorporate a preincubation step with P5P. The resulting slight increase in the overall random error may be diminished when an optimized heating coil is supplied by the manufacturer.
Myocardial infarct (defined allowable error, 8 U/L; critical activity, 41 U/L). In the case of the revised SMAC method it is the random component that is quite large, although only slightly larger than that of the original method.
Slightly improved precision is expected with a single large heating coil that the manufacturer is in the process of developing.
The systematic error component for the aca (and hence for SMAC, because its calibration was adjusted to agree with the ace) vs the IFCC method is larger than might be expected if the method were a direct adaptation of the IFCC method. However, the revised aca method is based on a re-optimization of conditions based on the principles of the IFCC-recommended method5 and hence does not show exact agreement.
Clinical studies. We evaluated the clinical performance of these methods.
From a group of 57 healthy donors, we estimated the upper and lower limits of a 95% logarithmic interval to be 18 U/L and 46 U/L, a wider range than reported by Naccarato et al. Clin. Chim. Acta 54, 127-129 (1974). 6. Rosalki, S. B., and Bayoumi, R. A., Activation by pyridoxal-5'-phosphate of aspartate aminotransferase in serum of patients with heart and liver disease. Clin. Chim. Acta 59, 357-360 (1979 
